Does a simple sarcopenia screening test predict future adverse events in patients with heart failure?
The sarcopenia screening test can be used to predict future adverse events in patients with HF.
Cx43 and N-cadherin are potential therapeutic targets in the promotion of healing of venous leg ulcers, by acting at least in part through distinct contributions of cell adhesion, migration, proliferation and cytoskeletal dynamics.